Redko Labs research notes · October 13, 2026
Why this field deserves attention
Stanford AIMI centers its work on responsible development and implementation of AI in medicine and imaging. Better models create a parallel need for stronger evaluation and usable clinical workflows.
One company idea to explore
A research-use imaging quality tool that identifies dataset inconsistencies, tracks acquisition differences, and reports where model performance changes across sites.
A possible first customer
Imaging research teams, medical AI developers, and organizations preparing carefully governed validation studies.
The first experiment
Start with appropriately licensed, de-identified research data. Compare flagged errors with expert review, measure false alarms, and demonstrate how a dataset shift changes a benchmark result.
What a founding team might bring
Computer vision, biomedical engineering, radiology research, statistics, data engineering, and human factors.
What must be resolved
Define the intended use before making claims. Research tooling does not establish clinical safety or permission to process patient data. Diagnostic uses need a separate regulatory and clinical plan.
This concept is a starting hypothesis from Redko Labs. Bring a different idea, challenge the assumptions, or apply without an idea. The work begins with evidence.
Bring the question.
Build the evidence.
Apply on a rolling basis, with an idea, a company, or the ambition to find your starting point.
Sources and research communities
Universities and organizations are independent of Redko Labs. Their inclusion describes public research activity, not a partnership, endorsement, facility entitlement, or recruitment agreement.
See how the curriculum supports this work